Quantum-Si Incorporated (NASDAQ:QSI - Get Free Report)'s stock price traded down 0.5% during trading on Wednesday . The stock traded as low as $0.86 and last traded at $0.8620. Approximately 2,249,786 shares traded hands during mid-day trading, a decline of 51% from the average daily volume of 4,623,178 shares. The stock had previously closed at $0.8662.
Wall Street Analyst Weigh In
Separately, Weiss Ratings lowered shares of Quantum-Si from a "sell (d-)" rating to a "sell (e+)" rating in a report on Wednesday, July 8th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Reduce" and an average target price of $1.00.
View Our Latest Analysis on QSI
Quantum-Si Price Performance
The company's 50-day moving average price is $0.97 and its 200-day moving average price is $0.99. The company has a market cap of $187.71 million, a P/E ratio of -1.69 and a beta of 3.20.
Quantum-Si (NASDAQ:QSI - Get Free Report) last issued its quarterly earnings results on Thursday, May 7th. The company reported ($0.10) EPS for the quarter, beating analysts' consensus estimates of ($0.12) by $0.02. The company had revenue of $0.26 million for the quarter, compared to analyst estimates of $0.30 million. Quantum-Si had a negative return on equity of 47.35% and a negative net margin of 5,605.88%. On average, equities research analysts predict that Quantum-Si Incorporated will post -0.49 EPS for the current year.
Insider Activity at Quantum-Si
In related news, CFO Jeffry R. Keyes sold 37,381 shares of the stock in a transaction on Tuesday, April 21st. The shares were sold at an average price of $0.99, for a total transaction of $37,007.19. Following the completion of the transaction, the chief financial officer owned 1,732,582 shares in the company, valued at approximately $1,715,256.18. This represents a 2.11% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Jeffrey Alan Hawkins sold 83,712 shares of the firm's stock in a transaction on Monday, April 20th. The shares were sold at an average price of $1.01, for a total transaction of $84,549.12. Following the completion of the transaction, the chief executive officer directly owned 3,776,135 shares of the company's stock, valued at approximately $3,813,896.35. This trade represents a 2.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 219,552 shares of company stock worth $216,114 in the last 90 days. Company insiders own 22.04% of the company's stock.
Hedge Funds Weigh In On Quantum-Si
Large investors have recently modified their holdings of the business. Renaissance Technologies LLC bought a new position in shares of Quantum-Si in the 1st quarter valued at about $91,000. Hollencrest Capital Management boosted its position in Quantum-Si by 301.1% during the first quarter. Hollencrest Capital Management now owns 40,111 shares of the company's stock valued at $31,000 after purchasing an additional 30,111 shares during the last quarter. Virtu Financial LLC acquired a new position in Quantum-Si during the fourth quarter valued at approximately $262,000. Invesco Ltd. grew its stake in Quantum-Si by 36.2% in the fourth quarter. Invesco Ltd. now owns 402,821 shares of the company's stock valued at $443,000 after purchasing an additional 107,093 shares in the last quarter. Finally, XTX Topco Ltd grew its stake in Quantum-Si by 206.9% in the fourth quarter. XTX Topco Ltd now owns 461,982 shares of the company's stock valued at $508,000 after purchasing an additional 311,450 shares in the last quarter. 39.90% of the stock is currently owned by institutional investors and hedge funds.
Quantum-Si Company Profile
(
Get Free Report)
Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.
Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Quantum-Si, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.
While Quantum-Si currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
